Figure 1From: Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicityEffects of in vitro addition of Infliximab (10, 50 and 100 μg/ml) to the cultures from active patients. (a) Expansion of Vγ9Vδ2 T lymphocytes (%); (b) TNF-RII (MESF); (c) IFN-γ content (%) and (d) granzyme release (mOD).Back to article page